Butterfly Network vs Alan
In-depth comparison — valuation, funding, investors, founders & more
🇺🇸 United States · John Martin
Valuation
$1.5B
Total Funding
$700M
500-1000 employees
🇫🇷 France · Jean-Charles Samuelian
Valuation
$1.4B
Total Funding
$220M
500-1000 employees
Analyst Summary
Generated from real data · No AI hallucinations
Both Butterfly Network and Alan compete directly in the AI Healthcare space, making this a head-to-head matchup within the same market segment. Butterfly Network produces the Butterfly iQ, a handheld ultrasound device powered by a proprietary semiconductor chip that replaces traditional piezoelectric transducer arrays with a single silicon chip capable of whole-body imaging. Alan is an AI-powered health insurance platform that combines employer group health insurance products with a digital health companion application, using AI to personalise member health recommendations, streamline claims processing, and provide on-demand access to telehealth and mental health resources.
Butterfly Network ($1.5B) is valued slightly higher than Alan ($1.4B). On the funding side, Butterfly Network has raised $700M in total — $480M more than Alan's $220M.
Butterfly Network has 5 years more market experience, having been founded in 2011 compared to Alan's 2016 founding. In terms of growth stage, Butterfly Network is at Public while Alan is at Series D — a meaningful difference for investors evaluating risk and upside.
Butterfly Network operates out of 🇺🇸 United States while Alan is based in 🇫🇷 France, giving each a distinct home-market advantage. On Awaira's 0–100 composite score, both companies are closely matched — Butterfly Network scores 85 and Alan scores 83.
Metrics Comparison
| Metric | Butterfly Network | Alan |
|---|---|---|
💰Valuation | $1.5BWINS | $1.4B |
📈Total Funding | $700MWINS | $220M |
📅Founded | 2011 | 2016WINS |
🚀Stage | Public | Series D |
👥Employees | 500-1000 | 500-1000 |
🌍Country | United States | France |
🏷️Category | AI Healthcare | AI Healthcare |
⭐Awaira Score | 85WINS | 83 |
Key Differences
Valuation gap: Butterfly Network is valued 1.1x higher ($1.5B vs $1.4B)
Funding gap: Butterfly Network has raised $480M more ($700M vs $220M)
Market experience: Butterfly Network has 5 years more (founded 2011 vs 2016)
Growth stage: Butterfly Network is at Public vs Alan at Series D
Market base: 🇺🇸 Butterfly Network (United States) vs 🇫🇷 Alan (France)
Direct competitors: Both operate in the AI Healthcare market segment
Awaira Score: Butterfly Network scores 85/100 vs Alan's 83/100
Which Should You Choose?
Use these signals to make the right call
Choose Butterfly Network if…
Top Pick- ✓Higher Awaira Score — 85/100 vs 83/100
- ✓More established by valuation ($1.5B)
- ✓Stronger investor backing — raised $700M
- ✓More market experience — founded in 2011
- ✓United States-based for regional compliance or proximity
- ✓Butterfly Network produces the Butterfly iQ, a handheld ultrasound device powered by a proprietary semiconductor chip that replaces traditional piezoelectric transducer arrays with a single silicon chip capable of whole-body imaging
Choose Alan if…
- ✓France-based for regional compliance or proximity
- ✓Alan is an AI-powered health insurance platform that combines employer group health insurance products with a digital health companion application, using AI to personalise member health recommendations, streamline claims processing, and provide on-demand access to telehealth and mental health resources